Document is current
Any future updates will be listed below
-
Authors
Jelodar, Mohsen Gholinataj
Hoseinzadeh, Farahnaz
Mirzaei, Samaneh
Falahati, Zahra
Saghafi, Fatemeh
-
Clinical Trials BETA
Clinical trials referenced in this document:
irct20190810044500n29 at Iranian Registry of Clinical TrialsDocuments that mention this clinical trial
Exploring pentoxifylline as an alternative treatment for dexamethasone in diabetic patients with COVID-19: a randomized controlled trial
https://doi.org/10.1186/s40001-025-02678-1
- License Information
-
More Information
Article History
Received: 7 March 2025
Accepted: 11 May 2025
First Online: 1 July 2025
Declarations
:
: All stages of this study were approved by the ethics committee of Shahid Sadoughi University of Medical Sciences of Yazd (Ethic ID: IR.SSU.MEDICINE.REC.1401.198). According to the research ethics guide, all patient information was completely confidential and all stages of the research were performed with patient satisfaction.
: Consent for publication was agreed upon in the written consent forms signed by patients.
: The authors declare no competing interests.
